You are here: Home » PTI Stories » National » News
Business Standard

Glenmark gets USFDA nod for generic version of acne treatment gel

Press Trust of India  |  New Delhi 

Friday said it has received final approval from the US health regulator for its generic version of gel used in treatment of

The approval granted to Inc, USA (Glenmark) by the Food & Drug Administration (USFDA) is for for and Gel, 1 per cent|5 per cent, a generic version of BenzaClin1 Gel, 1 per cent|5 per cent, of Valeant Bermuda, the company said in a statement.

Citing IQVIATM sales data, Glenmark said Gel, 1 per cent |5 per cent had sales of USD 99.4 million in the 12-month period ended January 2019.

Glenmark's current portfolio consists of 151 products authorised for distribution in the US with 53 ANDA's (abbreviated new drug applications) pending approval with the

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, March 15 2019. 15:45 IST